Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Tumor Suppressor ARF (CDKN2A) (AA 72-101) Antikörper

Der Kaninchen Polyklonal anti-Tumor Suppressor ARF Antikörper wird verwendet zum Nachweis von Tumor Suppressor ARF in Proben von Human. Er wurde validiert für IHC (p), FACS und WB.
Produktnummer ABIN7876617
631,13 €
Zzgl. Versandkosten 20,00 € und MwSt
400 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Tumor Suppressor ARF (CDKN2A) (AA 72-101) Antikörper (ABIN7876617)

Target

Tumor Suppressor ARF (CDKN2A)

Reaktivität

Human

Wirt

  • 2
  • 1
Kaninchen

Klonalität

  • 3
Polyklonal

Konjugat

  • 3
Unkonjugiert

Applikation

  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Western Blotting (WB)
  • Bindungsspezifität

    • 2
    • 1
    AA 72-101

    Verwendungszweck

    Tumor suppressor ARF Antibody / CDKN2A / MLM

    Aufreinigung

    Antigen affinity purified

    Immunogen

    A portion of amino acids 72-101 from the human protein was used as the immunogen for the Tumor suppressor ARF antibody.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    The stated application concentrations are suggested starting points. Titration of the Tumor suppressor ARF antibody may be required due to differences in protocols and secondary/substrate sensitivity.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    In 1X PBS, pH 7.4, with 0.09 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Aliquot the Tumor suppressor ARF antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
  • Target

    Tumor Suppressor ARF (CDKN2A)

    Andere Bezeichnung

    Tumor suppressor ARF

    Hintergrund

    This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene, this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.

    UniProt

    Q8N726
Sie sind hier:
Chat with us!